Company intelligence / Profile preview

Brian Marron Drug Discovery Consulting

Ownership: Private
Development stage: Other

Overview

Brian Marron Drug Discovery Consulting is a specialized consultancy led by industry veteran Brian Marron, offering strategic guidance in drug discovery and development. The firm supports clients with expertise in medicinal chemistry, lead optimization, formulation development, CRO management, and intellectual property evaluation. The founder has contributed to the advancement of therapeutics such as relutrigine (PRAX-562) and Prax-20 through prior roles at major pharmaceutical companies[2].

Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Brian Marron Drug Discovery Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brian Marron Drug Discovery Consulting.

Explore the full profile